Skip to main content

Peer Review reports

From: Bexarotene inhibits the viability of non-small cell lung cancer cells via slc10a2/PPARγ/PTEN/mTOR signaling pathway

Original Submission
2 Dec 2015 Submitted Original manuscript
1 Nov 2016 Author responded Author comments - Xinghao Ai
2 Jun 2016 Reviewed Reviewer Report - Esther Black
12 Jul 2016 Reviewed Reviewer Report - Samir Bhattacharya
Resubmission - Version 2
1 Nov 2016 Submitted Manuscript version 2
13 Dec 2016 Author responded Author comments - Xinghao Ai
15 Nov 2016 Reviewed Reviewer Report - Esther Black
12 Nov 2016 Reviewed Reviewer Report - Samir Bhattacharya
Resubmission - Version 3
13 Dec 2016 Submitted Manuscript version 3
16 Apr 2017 Author responded Author comments - Xinghao Ai
27 Mar 2017 Reviewed Reviewer Report - Esther Black
Resubmission - Version 4
16 Apr 2017 Submitted Manuscript version 4
14 Oct 2017 Author responded Author comments - Xinghao Ai
13 Jun 2017 Reviewed Reviewer Report - Esther Black
Resubmission - Version 5
14 Oct 2017 Submitted Manuscript version 5
28 Dec 2017 Author responded Author comments - Xinghao Ai
Resubmission - Version 6
28 Dec 2017 Submitted Manuscript version 6
24 Jan 2018 Author responded Author comments - Xinghao Ai
Resubmission - Version 7
24 Jan 2018 Submitted Manuscript version 7
28 Feb 2018 Author responded Author comments - Xinghao Ai
Resubmission - Version 8
28 Feb 2018 Submitted Manuscript version 8
Publishing
13 Mar 2018 Editorially accepted
11 Apr 2018 Article published 10.1186/s12885-018-4224-x

You can find further information about peer review here.

Back to article page